“DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients With CNS Glial Tumors. First Results”. 2026. Voprosy Onkologii 72 (2): OF-2504. https://doi.org/10.37469/0507-3758-2026-72-2-OF-2504.